ArticleActa pharmaceutica Sinica. B2026
Preclinical evaluation of GW406108X, a broad-spectrum therapeutic blocking ULK1/2-mediated autophagy to inhibit enterovirus replication.
Yuhui Deborah Fong et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.